BRAIN BIOTECH AG (BNN.DE) Stock Price, Forecast & Analysis
FRA:BNN • DE0005203947
BNN.DE Key Statistics, Chart & Performance
The current stock price of BNN.DE is 2.54 EUR. In the past month the price increased by 9.48%. In the past year, price decreased by -2.68%.
BNN.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to BNN.DE. When comparing the yearly performance of all stocks, BNN.DE is a bad performer in the overall market: 85.04% of all stocks are doing better.
BNN.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNN.DE. BNN.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
BNN.DE Financial Highlights
Over the last trailing twelve months BNN.DE reported a non-GAAP Earnings per Share(EPS) of -0.49. The EPS increased by 15.13% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.88% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BNN.DE Forecast & Estimates
9 analysts have analysed BNN.DE and the average price target is 5.34 EUR. This implies a price increase of 110.43% is expected in the next year compared to the current price of 2.54.
For the next year, analysts expect an EPS growth of 3.78% and a revenue growth -2.53% for BNN.DE
BNN.DE Ownership
BNN.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SY1 | SYMRISE AG | 19.05 | 10.843B | ||
| AKU1 | AKZO NOBEL N.V. | 13.68 | 10.263B | ||
| AKZA | AKZO NOBEL N.V. | 13.59 | 10.198B | ||
| EVK | EVONIK INDUSTRIES AG | 12.52 | 6.892B | ||
| SYENS | SYENSQO SA | 9.19 | 5.027B | ||
| AKE | ARKEMA | 12.33 | 4.712B | ||
| UMI | UMICORE | 12.88 | 4.44B | ||
| NVJP | UMICORE | 12.81 | 4.418B | ||
| WCH | WACKER CHEMIE AG | 123.2 | 4.214B | ||
| RBT | ROBERTET SA | 17.51 | 1.901B |
Related stock screener links
View all stocks in the Specialty Chemicals Industry | View all stocks in the Materials Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About BNN.DE
Company Profile
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 281 full-time employees. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Company Info
BRAIN BIOTECH AG
Darmstaedter Strasse 34-36
Zwingenberg HESSEN DE
Employees: 296
Phone: 49625193310
BRAIN BIOTECH AG / BNN.DE FAQ
What does BNN do?
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 281 full-time employees. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
What is the current price of BNN stock?
The current stock price of BNN.DE is 2.54 EUR. The price increased by 0.4% in the last trading session.
Does BRAIN BIOTECH AG pay dividends?
BNN.DE does not pay a dividend.
How is the ChartMill rating for BRAIN BIOTECH AG?
BNN.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is BRAIN BIOTECH AG (BNN.DE) stock traded?
BNN.DE stock is listed on the Frankfurt Stock Exchange exchange.
Can you provide the ownership details for BNN stock?
You can find the ownership structure of BRAIN BIOTECH AG (BNN.DE) on the Ownership tab.